Dr. Jared Weiss, Vice President of the GRACE Board of Directors and GRACE faculty, discusses the ADAURA trial; the first global trial for an EGFR inhibitor to show statistically significant and clinically meaningful benefit in adjuvant treatment of lung cancer.
Dr. Jared Weiss, Vice President of the GRACE Board of Directors and GRACE faculty, discusses the ADAURA trial; the first global trial for an EGFR inhibitor to show statistically significant and clinically meaningful benefit in adjuvant treatment of lung cancer.
read more
read less
